{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T10:17:59Z","timestamp":1762078679905},"reference-count":32,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2005,5,1]],"date-time":"2005-05-01T00:00:00Z","timestamp":1114905600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Chest"],"published-print":{"date-parts":[[2005,5]]},"DOI":"10.1378\/chest.127.5.1828","type":"journal-article","created":{"date-parts":[[2005,5,11]],"date-time":"2005-05-11T23:03:47Z","timestamp":1115852627000},"page":"1828-1835","source":"Crossref","is-referenced-by-count":30,"title":["Use of Recombinant Activated Factor VII for Bleeding Following Operations Requiring Cardiopulmonary Bypass"],"prefix":"10.1016","volume":"127","author":[{"given":"Robert J.","family":"DiDomenico","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Malek G.","family":"Massad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacques","family":"Kpodonu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R. Antonio","family":"Navarro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander S.","family":"Geha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1378\/chest.127.5.1828_bib1","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1001\/archsurg.133.4.442","article-title":"Re-exploration for hemorrhage following coronary artery bypass grafting: incidence and risk factors","volume":"133","author":"Dacey","year":"1998","journal-title":"Arch Surg"},{"key":"10.1378\/chest.127.5.1828_bib2","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/0003-4975(94)00995-3","article-title":"Re-sternotomy for bleeding after cardiac operation: a marker for increased morbidity and mortality","volume":"59","author":"Unsworth-White","year":"1995","journal-title":"Ann Thorac Surg"},{"key":"10.1378\/chest.127.5.1828_bib3","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/S0022-5223(96)70380-X","article-title":"Re-exploration for bleeding is a risk factor for adverse outcomes after cardiac operations","volume":"111","author":"Moulton","year":"1996","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1378\/chest.127.5.1828_bib4","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1097\/00004311-200404230-00011","article-title":"Protamine and protamine reactions","volume":"42","author":"Park","year":"2004","journal-title":"Int Anesthesiol Clin"},{"key":"10.1378\/chest.127.5.1828_bib5","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.2165\/00003495-200262150-00003","article-title":"Pharmacologic strategies to decrease transfusion requirements in patients undergoing surgery","volume":"62","author":"Porte","year":"2002","journal-title":"Drugs"},{"key":"10.1378\/chest.127.5.1828_bib6","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1016\/S0140-6736(00)02225-X","article-title":"Blood coagulation","volume":"355","author":"Dahlb\u00e4ck","year":"2000","journal-title":"Lancet"},{"key":"10.1378\/chest.127.5.1828_bib7","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1046\/j.1538-7836.2003.00190.x","article-title":"Cellular mechanisms of the hemostatic effects of desmopressin (DDAVP)","volume":"1","author":"Kaufmann","year":"2003","journal-title":"J Thromb Haemost"},{"key":"10.1378\/chest.127.5.1828_bib8","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1086\/502114","article-title":"Hemorrhage after coronary artery bypass graft procedures","volume":"24","author":"Herwaldt","year":"2003","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1378\/chest.127.5.1828_bib9","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1046\/j.1365-2141.2001.02878.x","article-title":"Successful treatment of severe intra-abdominal bleeding associated with disseminated intravascular coagulation using recombinant activated factor VII","volume":"113","author":"Moscardo","year":"2001","journal-title":"Br J Haematol"},{"key":"10.1378\/chest.127.5.1828_bib10","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1097\/00000542-200206000-00039","article-title":"Synthetic factor VIIa to treat dilutional coagulopathy during posterior spinal fusion in two children","volume":"96","author":"Tobias","year":"2002","journal-title":"Anesthesiology"},{"key":"10.1378\/chest.127.5.1828_bib11","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1097\/00000542-200206000-00040","article-title":"Use of recombinant factor VIIa (NovoSeven) to reduce postoperative bleeding after total hip arthroplasty in a patient with cirrhosis and thrombocytopenia","volume":"96","author":"Slappendel","year":"2002","journal-title":"Anesthesiology"},{"key":"10.1378\/chest.127.5.1828_bib12","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1097\/00000542-200206000-00041","article-title":"Treatment of bleeding in severe necrotizing pancreatitis with recombinant factor VIIa [letter]","volume":"96","author":"Svartholm","year":"2002","journal-title":"Anesthesiology"},{"key":"10.1378\/chest.127.5.1828_bib13","first-page":"1172","article-title":"Successful treatment with recombinant factor VIIa for intractable bleeding at pelvic surgery","volume":"101","author":"Danilos","year":"2003","journal-title":"Obstet Gynecol"},{"key":"10.1378\/chest.127.5.1828_bib14","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1227\/01.NEU.0000068830.54968.A8","article-title":"Recombinant activated factor VII for the rapid correction of coagulopathy in nonhemophilic neurosurgical patients","volume":"53","author":"Park","year":"2003","journal-title":"Neurosurgery"},{"key":"10.1378\/chest.127.5.1828_bib15","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1111\/j.1471-0528.2004.00058.x","article-title":"Prolonged treatment of massive postpartum haemorrhage with recombinant factor VIIa: case report and review of the literature","volume":"111","author":"Boehlen","year":"2004","journal-title":"BJOG"},{"key":"10.1378\/chest.127.5.1828_bib16","doi-asserted-by":"crossref","first-page":"S121","DOI":"10.1097\/00001721-200004001-00023","article-title":"Effect of the administration of recombinant activated factor VII (rFVIIa; NovoSeven) in the management of severe uncontrolled bleeding in patients undergoing heart valve replacement surgery","volume":"11(suppl)","author":"Aldouri","year":"2000","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1378\/chest.127.5.1828_bib17","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1213\/00000539-200108000-00009","article-title":"An effective treatment of severe intractable bleeding after valve repair by one single dose of activated recombinant factor VII","volume":"93","author":"Hendriks","year":"2001","journal-title":"Anesth Analg"},{"key":"10.1378\/chest.127.5.1828_bib18","doi-asserted-by":"crossref","first-page":"2182","DOI":"10.1016\/S0003-4975(02)04105-X","article-title":"Activated recombinant factor VII for control of diffuse bleeding after implantation of ventricular assist device","volume":"74","author":"Potapov","year":"2002","journal-title":"Ann Thorac Surg"},{"key":"10.1378\/chest.127.5.1828_bib19","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1053\/jcan.2002.126927","article-title":"Successful treatment of refractory bleeding with recombinant factor VIIa after redo coronary artery bypass graft surgery","volume":"16","author":"von Heymann","year":"2002","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"10.1378\/chest.127.5.1828_bib20","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1016\/S0003-4975(02)03700-1","article-title":"Recombinant factor VIIa after aortic valve replacement in a patient with osteogenesis imperfecta","volume":"74","author":"Kastrup","year":"2002","journal-title":"Ann Thorac Surg"},{"key":"10.1378\/chest.127.5.1828_bib21","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1067\/mtc.2002.126038","article-title":"Fatal thrombosis after administration of activated prothrombin complex concentrates in a patient supported by extracorporeal membrane oxygenation who had received activated recombinant factor VII","volume":"124","author":"Bui","year":"2002","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1378\/chest.127.5.1828_bib22","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1007\/BF03018648","article-title":"Successful treatment using recombinant factor VIIa for severe bleeding post cardiopulmonary bypass","volume":"50","author":"Naik","year":"2003","journal-title":"Can J Anaesth"},{"key":"10.1378\/chest.127.5.1828_bib23","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1097\/00000542-200306000-00034","article-title":"Treatment of excessive bleeding in Jehovah's witness patients after cardiac surgery with recombinant factor VIIa (NovoSeven)","volume":"98","author":"Tanaka","year":"2003","journal-title":"Anesthesiology"},{"key":"10.1378\/chest.127.5.1828_bib24","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1097\/00130478-200301000-00009","article-title":"Recombinant factor VIIa to treat bleeding after cardiac surgery in an infant","volume":"4","author":"Tobias","year":"2003","journal-title":"Pediatr Crit Care Med"},{"key":"10.1378\/chest.127.5.1828_bib25","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1097\/01.PCC.0000074276.20537.0A","article-title":"Recombinant activated factor VII for life-threatening pulmonary hemorrhage after pediatric cardiac surgery","volume":"4","author":"Leibovitch","year":"2003","journal-title":"Pediatr Crit Care Med"},{"key":"10.1378\/chest.127.5.1828_bib26","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1053\/ejvs.2002.1887","article-title":"The use of recombinant activated factor VII to control bleeding during repair of suprarenal abdominal aortic aneurysm","volume":"26","author":"Wahlgren","year":"2003","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1378\/chest.127.5.1828_bib27","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1177\/0310057X0303100418","article-title":"Recombinant activated factor VII for exsanguinating hemorrhage post bilateral lung transplantation for extra-corporeal lung support-dependent respiratory failure","volume":"31","author":"Lucey","year":"2003","journal-title":"Anaesth Intensive Care"},{"key":"10.1378\/chest.127.5.1828_bib28","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1016\/j.jtcvs.2003.12.021","article-title":"Activated recombinant factor VII for refractory bleeding during extracorporeal membrane oxygenation","volume":"127","author":"Verrijckt","year":"2004","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1378\/chest.127.5.1828_bib29","doi-asserted-by":"crossref","first-page":"S248","DOI":"10.1007\/s00134-002-1472-6","article-title":"Ongoing NovoSeven trials","volume":"28(suppl)","author":"Erhardtsen","year":"2002","journal-title":"Intensive Care Med"},{"key":"10.1378\/chest.127.5.1828_bib30","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1097\/00000539-200205000-00070","article-title":"Caveat against the use of activated recombinant factor VII for intractable bleeding in cardiac surgery","volume":"94","author":"Dietrich","year":"2002","journal-title":"Anesth Analg"},{"key":"10.1378\/chest.127.5.1828_bib31","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1016\/S0022-5223(03)01198-X","article-title":"Caveat against the use of FEIBA in combination with recombinant factor VIIa","volume":"126","author":"von Heymann","year":"2003","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1378\/chest.127.5.1828_bib32","unstructured":"Medical Economics Co. 2003 drug topics red book.2003 Medical Economics Co.. Montvale, NJ:"}],"container-title":["Chest"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369215347565?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369215347565?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,1,25]],"date-time":"2024-01-25T21:58:56Z","timestamp":1706219936000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0012369215347565"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,5]]},"references-count":32,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2005,5]]}},"alternative-id":["S0012369215347565"],"URL":"https:\/\/doi.org\/10.1378\/chest.127.5.1828","relation":{},"ISSN":["0012-3692"],"issn-type":[{"value":"0012-3692","type":"print"}],"subject":[],"published":{"date-parts":[[2005,5]]}}}